US Stock MarketDetailed Quotes

ARPO Aerpio Pharmaceuticals

Watchlist

0.000
0.0000.00%

Close Nov 6 09:30 ET

0Market Cap0.00P/E (TTM)

Aerpio Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q2)Jun 30, 2021

(Q1)Mar 31, 2021

(FY)Dec 31, 2020

(Q4)Dec 31, 2020

(Q3)Sep 30, 2020

(Q2)Jun 30, 2020

(Q1)Mar 31, 2020

(FY)Dec 31, 2019

(Q4)Dec 31, 2019

(Q3)Sep 30, 2019

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-121.64%-2.23M

6.93%-3.67M

77.42%-5.38M

0.91%-4.82M

-45.21%-6.92M

299.99%10.29M

56.60%-3.94M

-310.68%-23.85M

21.34%-4.87M

23.45%-4.76M

Net income from continuing operations

-147.52%-4.41M

-13.35%-4.44M

81.46%-4.32M

-6.11%-4.72M

-6.61%-4.96M

263.21%9.28M

53.86%-3.92M

-123.83%-23.27M

47.81%-4.45M

-140.29%-4.65M

Operating gains losses

----

--94.71K

----

Depreciation and amortization

-22.53%11.67K

11.11%16.78K

-19.63%61.48K

-31.63%15.6K

-22.15%15.72K

-26.55%15.07K

16.26%15.1K

63.86%76.5K

100.54%22.81K

73.34%20.19K

Other non cash items

----

34.62%71.94K

--0

--9.59K

--62.35K

--53.44K

----

Change In working capital

122.47%1.52M

196.81%412.51K

-31.29%-2.48M

-319.88%-432.09K

-195.56%-2.31M

878.57%682.74K

65.08%-426.08K

-270.49%-1.89M

-88.12%196.52K

95.79%-781.28K

-Change in prepaid assets

426.50%257.08K

206.81%253.1K

-144.90%-199.02K

-123.92%-54.32K

12.80%-148.46K

-184.93%-78.74K

-80.07%82.49K

200.45%443.24K

154.45%227.15K

-285.76%-170.25K

-Change in payables and accrued expense

-75.61%106.6K

142.78%289.15K

35.23%-1.44M

-257.37%-619.31K

-50,171.34%-578.32K

231.67%437.06K

60.56%-675.86K

-218.92%-2.22M

-109.56%-173.3K

-99.83%1.16K

-Change in other current assets

256.08%1.16M

-177.56%-129.74K

-629.72%-869.13K

56.34%221.54K

-158.48%-1.58M

19.33%324.42K

110.41%167.29K

59.41%-119.1K

-49.28%141.71K

10.19%-612.19K

-Change in other working capital

----

1,983.33%20K

----

104.80%960

----

Cash from discontinued investing activities

Operating cash flow

-121.64%-2.23M

6.93%-3.67M

77.42%-5.38M

0.91%-4.82M

-45.21%-6.92M

299.99%10.29M

56.60%-3.94M

-310.68%-23.85M

21.34%-4.87M

23.45%-4.76M

Investing cash flow

Cash flow from continuing investing activities

91.97%-19.03K

-59.47%-6.83K

-525.01%-236.95K

100.01%1

79.50%-4.28K

Net PPE purchase and sale

----

91.97%-19.03K

--0

-59.47%-6.83K

----

-525.01%-236.95K

100.01%1

79.50%-4.28K

Cash from discontinued investing activities

Investing cash flow

----

91.97%-19.03K

--0

-59.47%-6.83K

----

-525.01%-236.95K

100.01%1

79.50%-4.28K

Financing cash flow

Cash flow from continuing financing activities

34.49K

70.28K

9.48M

143.53K

9.34M

Net common stock issuance

----

--9.74M

--0

--9.74M

----

--0

----

Proceeds from stock option exercised by employees

---45.98K

--70.28K

--143.53K

----

--0

----

Net other financing activities

----

---402.8K

--0

----

Cash from discontinued financing activities

Financing cash flow

--34.49K

--70.28K

--9.48M

--143.53K

--9.34M

--0

----

Net cash flow

Beginning cash position

12.79%39.01M

10.59%42.6M

-38.47%38.52M

8.97%47.28M

-6.84%44.86M

-35.26%34.58M

-38.47%38.52M

208.99%62.61M

-36.94%43.39M

-29.99%48.16M

Current changes in cash

-121.33%-2.19M

8.72%-3.6M

116.94%4.08M

3.86%-4.68M

150.71%2.42M

295.22%10.28M

57.14%-3.94M

-156.88%-24.09M

21.45%-4.87M

-19,917.13%-4.77M

End cash Position

-17.94%36.82M

12.79%39.01M

10.59%42.6M

8.97%47.28M

-6.84%44.86M

-35.26%34.58M

-38.47%38.52M

-36.94%43.39M

Free cash flow

-121.66%-2.23M

6.93%-3.67M

77.57%-5.4M

0.91%-4.82M

-45.22%-6.92M

295.22%10.28M

57.14%-3.94M

-312.07%-24.09M

21.45%-4.87M

23.63%-4.77M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q2)Jun 30, 2021	(Q1)Mar 31, 2021	(FY)Dec 31, 2020	(Q4)Dec 31, 2020	(Q3)Sep 30, 2020	(Q2)Jun 30, 2020	(Q1)Mar 31, 2020	(FY)Dec 31, 2019	(Q4)Dec 31, 2019	(Q3)Sep 30, 2019
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-121.64%-2.23M	6.93%-3.67M	77.42%-5.38M	0.91%-4.82M	-45.21%-6.92M	299.99%10.29M	56.60%-3.94M	-310.68%-23.85M	21.34%-4.87M	23.45%-4.76M
Net income from continuing operations	-147.52%-4.41M	-13.35%-4.44M	81.46%-4.32M	-6.11%-4.72M	-6.61%-4.96M	263.21%9.28M	53.86%-3.92M	-123.83%-23.27M	47.81%-4.45M	-140.29%-4.65M
Operating gains losses	----	----	----	----	----	----	----	--94.71K	----	----
Depreciation and amortization	-22.53%11.67K	11.11%16.78K	-19.63%61.48K	-31.63%15.6K	-22.15%15.72K	-26.55%15.07K	16.26%15.1K	63.86%76.5K	100.54%22.81K	73.34%20.19K
Other non cash items	----	----	34.62%71.94K	--0	--0	--9.59K	--62.35K	--53.44K	----	----
Change In working capital	122.47%1.52M	196.81%412.51K	-31.29%-2.48M	-319.88%-432.09K	-195.56%-2.31M	878.57%682.74K	65.08%-426.08K	-270.49%-1.89M	-88.12%196.52K	95.79%-781.28K
-Change in prepaid assets	426.50%257.08K	206.81%253.1K	-144.90%-199.02K	-123.92%-54.32K	12.80%-148.46K	-184.93%-78.74K	-80.07%82.49K	200.45%443.24K	154.45%227.15K	-285.76%-170.25K
-Change in payables and accrued expense	-75.61%106.6K	142.78%289.15K	35.23%-1.44M	-257.37%-619.31K	-50,171.34%-578.32K	231.67%437.06K	60.56%-675.86K	-218.92%-2.22M	-109.56%-173.3K	-99.83%1.16K
-Change in other current assets	256.08%1.16M	-177.56%-129.74K	-629.72%-869.13K	56.34%221.54K	-158.48%-1.58M	19.33%324.42K	110.41%167.29K	59.41%-119.1K	-49.28%141.71K	10.19%-612.19K
-Change in other working capital	----	----	1,983.33%20K	----	----	----	----	104.80%960	----	----
Cash from discontinued investing activities
Operating cash flow	-121.64%-2.23M	6.93%-3.67M	77.42%-5.38M	0.91%-4.82M	-45.21%-6.92M	299.99%10.29M	56.60%-3.94M	-310.68%-23.85M	21.34%-4.87M	23.45%-4.76M
Investing cash flow
Cash flow from continuing investing activities			91.97%-19.03K	0	-59.47%-6.83K			-525.01%-236.95K	100.01%1	79.50%-4.28K
Net PPE purchase and sale	----	----	91.97%-19.03K	--0	-59.47%-6.83K	----	----	-525.01%-236.95K	100.01%1	79.50%-4.28K
Cash from discontinued investing activities
Investing cash flow	----	----	91.97%-19.03K	--0	-59.47%-6.83K	----	----	-525.01%-236.95K	100.01%1	79.50%-4.28K
Financing cash flow
Cash flow from continuing financing activities	34.49K	70.28K	9.48M	143.53K	9.34M	0	0	0	0
Net common stock issuance	----	----	--9.74M	--0	--9.74M	----	----	--0	--0	----
Proceeds from stock option exercised by employees	---45.98K	--70.28K	--143.53K	----	----	--0	--0	--0	----	----
Net other financing activities	----	----	---402.8K	--0	----	----	----	----	----	----
Cash from discontinued financing activities
Financing cash flow	--34.49K	--70.28K	--9.48M	--143.53K	--9.34M	--0	--0	--0	--0	----
Net cash flow
Beginning cash position	12.79%39.01M	10.59%42.6M	-38.47%38.52M	8.97%47.28M	-6.84%44.86M	-35.26%34.58M	-38.47%38.52M	208.99%62.61M	-36.94%43.39M	-29.99%48.16M
Current changes in cash	-121.33%-2.19M	8.72%-3.6M	116.94%4.08M	3.86%-4.68M	150.71%2.42M	295.22%10.28M	57.14%-3.94M	-156.88%-24.09M	21.45%-4.87M	-19,917.13%-4.77M
End cash Position	-17.94%36.82M	12.79%39.01M	10.59%42.6M	10.59%42.6M	8.97%47.28M	-6.84%44.86M	-35.26%34.58M	-38.47%38.52M	-38.47%38.52M	-36.94%43.39M
Free cash flow	-121.66%-2.23M	6.93%-3.67M	77.57%-5.4M	0.91%-4.82M	-45.22%-6.92M	295.22%10.28M	57.14%-3.94M	-312.07%-24.09M	21.45%-4.87M	23.63%-4.77M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data